Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vera Therapeutics, Inc.

22.57
-0.0400-0.18%
Post-market: 22.55-0.0200-0.09%19:42 EDT
Volume:2.04M
Turnover:47.42M
Market Cap:1.44B
PE:-6.28
High:23.81
Open:22.82
Low:22.41
Close:22.61
52wk High:51.61
52wk Low:18.53
Shares:63.82M
Float Shares:42.92M
Volume Ratio:1.02
T/O Rate:4.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5921
EPS(LYR):-2.7500
ROE:-54.83%
ROA:-30.24%
PB:3.08
PE(LYR):-8.21

Loading ...

Vera Therapeutics Unveils New Employee Compensation Plan with Inducement Stock Options and RSUs

Reuters
·
Aug 09

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 09

Stock Track | Vera Therapeutics (VERA) Plummets 5.96% as Q2 Losses Widen, Misses EPS Estimates

Stock Track
·
Aug 06

Vera Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 06

Vera Therapeutics Reports Progress in Clinical Trials

TIPRANKS
·
Aug 06

Vera Therapeutics Signs New Sales Agreement with TD Securities

TIPRANKS
·
Aug 06

BRIEF-Vera Therapeutics Files For Offering Of Up To $200 Million Class A Common Stock - Filing

Reuters
·
Aug 06

Vera Therapeutics Inc. Enters New $200 Million Sales Agreement with TD Cowen, Replacing 2022 Agreement

Reuters
·
Aug 06

Vera Therapeutics Files for Offering of up to $200 Mln Class a Common Stock - Filing

THOMSON REUTERS
·
Aug 06

Earnings Flash (VERA) Vera Therapeutics Posts Q2 Net Loss $1.20, vs. FactSet Est of $0.82 Loss

MT Newswires Live
·
Aug 05

Vera Therapeutics Q2 2025 EPS $(1.20) Misses $(0.83) Estimate, Vera Reported $556.8M In Cash, Cash Equivalents, And Marketable Securities

Benzinga
·
Aug 05

Vera Therapeutics Reports Q2 2025 Net Loss of $76.5 Million, EPS Down to $1.20 from $0.62 Year Over Year

Reuters
·
Aug 05

Vera Therapeutics Inc - to Submit Bla for Atacicept to FDA in Q4 2025

THOMSON REUTERS
·
Aug 05

Vera Therapeutics Shares Fall After Downgrade From Wolfe Research

MT Newswires Live
·
Aug 05

Wolfe Downgrades Vera Therapeutics to Peer Perform From Outperform

MT Newswires Live
·
Aug 04

Vera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

TIPRANKS
·
Aug 04

Vera Therapeutics (VERA) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Jul 14

Vera Therapeutics Announces Inducement Awards with Stock Options and RSUs for New Employees Under Nasdaq Rule

Reuters
·
Jul 11

Vera Therapeutics Pick of the Week at Smart Insider Following Patrick Enright's Stock Purchase

MT Newswires Live
·
Jul 01

Director Patrick G. Enright Reports Acquisition of Common Shares in Vera Therapeutics Inc

Reuters
·
Jun 26